Park Jae Kil, Kim Jae Jun, Moon Seok Whan
Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
Department of Thoracic and Cardiovascular Surgery, Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine, Uijeongbu, Korea.
J Thorac Dis. 2017 Oct;9(10):3693-3702. doi: 10.21037/jtd.2017.08.125.
Anastomotic leak is one of most significant causes of mortality after esophagectomy. Therefore, it is clinically valuable to detect anastomotic leak early after esophagectomy in esophageal cancer. The purpose of this study is to investigate the associations between routine postoperative laboratory findings and anastomotic leak and to analyze the laboratory findings to find out an independent predictive marker for anastomotic leak. In addition, this study compares cases treated with neoadjuvant therapy (NT) and those without (non-NT).
We retrospectively assessed the medical records of 201 consecutive cases that met this study's criteria from January 2009 to December 2016. All patients underwent curative and complete esophagectomy for intra-thoracic esophageal cancer. We compiled and analyzed routine laboratory findings from the day before surgery to the eighth postoperative day on a daily basis. Routine laboratory tests consisted of 26 separate tests, including complete blood cell counts, blood chemistries, as well as erythrocyte sedimentation rate and C-reactive protein (CRP). Barium esophagogram with chest computed tomography (CT) was performed on the seventh postoperative day to evaluate the presence of an anastomotic leak.
A total of 45 of 201 patients underwent NT. Anastomotic leaks were found in 23 (11.4%) of 201 patients (8 patients in NT and 15 patients in non-NT). White blood cell (WBC) from the second postoperative day (P=0.031, P=0.006, P=0.007, P=0.007, P=0.041, and P=0.003, respectively) and CRP from the third postoperative day (P=0.012, P<0.001, P=0.014, P<0.001, P=0.001, and P=0.006, respectively) were associated with anastomotic leak in non-NT; however, only CRP on the third, fifth, sixth, and seventh postoperative days (P=0.041, P=0.037, P=0.002, and P=0.003, respectively) was associated with anastomotic leak in NT. The CRP level on the third postoperative day was a significant independent predictive marker of anastomotic leak (P=0.041, odd ratio (OR) 1.056, 95% confidential interval (CI): 1.002-1.113) and had a significant diagnostic cutoff value for the development of anastomotic leak (non-NT: cutoff value 17.12 mg/dL, sensitivity 69.2%, specificity 78.1%, P<0.001, area 0.822; NT: cutoff value 16.42 mg/dL, sensitivity 80.0%, specificity 70.0%, P=0.042, area 0.7104).
There were divergent laboratory findings reflective of anastomotic leak between patients who underwent NT and those who did not. The CRP level on the third postoperative day had a significant cutoff value for early detection of anastomotic leak after esophagectomy in both NT and non-NT groups.
吻合口漏是食管癌切除术后最主要的死亡原因之一。因此,食管癌切除术后早期检测吻合口漏具有临床价值。本研究旨在探讨术后常规实验室检查结果与吻合口漏之间的关联,并分析实验室检查结果以找出吻合口漏的独立预测指标。此外,本研究还比较了接受新辅助治疗(NT)和未接受新辅助治疗(非NT)的病例。
我们回顾性评估了2009年1月至2016年12月期间符合本研究标准的201例连续病例的病历。所有患者均接受了根治性全胸段食管癌切除术。我们每天收集并分析从手术前一天到术后第八天的常规实验室检查结果。常规实验室检查包括26项单独检查,包括全血细胞计数、血液化学检查以及红细胞沉降率和C反应蛋白(CRP)。术后第七天进行食管钡餐造影及胸部计算机断层扫描(CT)以评估吻合口漏的情况。
201例患者中共有45例接受了NT。201例患者中有23例(11.4%)发生了吻合口漏(NT组8例,非NT组15例)。术后第二天的白细胞(WBC)(分别为P = 0.031、P = 0.006、P = 0.007、P = 0.007、P = 0.041和P = 0.003)以及术后第三天的CRP(分别为P = 0.012、P < 0.001、P = 0.014、P < 0.001、P = 0.001和P = 0.006)与非NT组的吻合口漏相关;然而,在NT组中,仅术后第三天、第五天、第六天和第七天的CRP(分别为P = 0.041、P = 0.037、P = 0.002和P = 0.003)与吻合口漏相关。术后第三天的CRP水平是吻合口漏的显著独立预测指标(P = 0.041,比值比(OR)1.056,95%可信区间(CI):1.002 - 1.113),并且对吻合口漏的发生具有显著的诊断临界值(非NT组:临界值17.12mg/dL,敏感性69.2%,特异性78.1%,P < <0.001,面积为0.822;NT组:临界值16.42mg/dL,敏感性80.0%,特异性70.0%,P = 0.042,面积为0.7104)。
接受NT和未接受NT的患者在反映吻合口漏的实验室检查结果方面存在差异。术后第三天的CRP水平在NT组和非NT组中均对食管癌切除术后吻合口漏的早期检测具有显著的临界值。